• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
QIU Mengru,WU Mingli.A case of fluvastatin-induced elevation and rhabdomyolysis[J].Journal Of Pharmaceutical Research,2021,40(2):138-140[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2512times   Download 2299次 QR Code for this article
Scan with your phone!
氟伐他汀致转氨酶升高并横纹肌溶解1例
仇梦如1,2,吴明丽1
Font:Larger+|Default|Smaller-
(1.济宁医学院附属医院,山东 济宁 272000;2.嘉祥县人民医院,山东 嘉祥 272400)
摘要:
1例79岁女性患者因冠心病给予氟伐他汀,同时给予阿司匹林、氯吡格雷、富马酸比索洛尔、单硝酸异山梨酯治疗。2月后出现双下肢无力伴疼痛、食欲不振,实验室检查:肌酸激酶(CK)50 774 U·L-1,丙氨酸转氨酶(ALT)706.9 U·L-1,天门冬氨酸转氨酶 (AST) 1 294 U·L-1。停用氟伐他汀,继续使用其他药物,并给予硫普罗宁及水飞蓟宾葡甲胺保肝治疗。次日复查CK 38 134 U·L-1。停药5 d后下肢无力症状消失,7 d后CK 2144,ALT 494.6,AST 189 U·L-1。1个月及3个月后随访,转氨酶及心肌酶均基本恢复正常。
关键词:  氟伐他汀  不良反应  转氨酶升高  横纹肌溶解
DOI:10.13506/j.cnki.jpr.2021.02.017
基金项目:
Publication Date:February 25, 2021
A case of fluvastatin-induced elevation and rhabdomyolysis
QIU Mengru1,2,WU Mingli1
(1.Affiliated Hospital of Jining Medical University,Jining 272000,China;2.People’s Hospital of Jiaxiang,Jining 272400,China)
Abstract:
A 79-year-old female patient with coronary heart disease received fluvastatin, meanwhile she was given aspirin, hydro clopidogrel, bisoprolol fumarate and isosorbide mononitrate. The patient developed weakness and pain in double lower limbs with loss of appetite two months after the first dose. Laboratory tests showed creatine kinase (CK) 50 774 U·L-1, alanine aminotransferase (ALT) 706.9 U·L-1, aspartate aminotransferase (AST) 1 294 U·L-1. Fluvastatin was withdrawn and other drugs continued. Meanwhile tiopronin and silibin meglumine were given for liver protection treatment. Laboratory tests showed CK 38 134 U·L-1 in the next day. After 5 days of fluvastatin withdrawn, the lower limbs weakness disappeared. Seven days after withdrawn, laboratory tests showed CK 2144 U·L-1, ALT 494.6 U·L-1, AST 189 U·L-1. Both hepatic transaminase and myocardial enzyme basically returned to normal at one month and three months of follow-up after withdrawn.
Key words:  Fluvastatin  Adverse Reactions  Hepatic Enzyme Elevation  Rhabdomyolysis
Today's Visits:464    Total Visits:2383159
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.